Form 4: Sarepta Exec's Tax-Related Stock Disposition
Insider Transaction Report
Sarepta Therapeutics' President of R&D and Tech Ops, Louise Rodino-Klapac, disposed of 4,582 shares of common stock to cover tax obligations from RSU vesting.
Summary
- Louise Rodino-Klapac, President, R&D and Tech Ops at Sarepta Therapeutics, Inc. (SRPT), reported a disposition of common stock.
- On November 17, 2025, 4,582 shares of Sarepta Therapeutics common stock were disposed of at a price of $18.42 per share.
- The disposition was made to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs) that were granted on November 16, 2021.
- Following this transaction, Louise Rodino-Klapac beneficially owns 224,030 shares of common stock directly.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is neither positive nor negative for the company's fundamentals or stock performance.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This is a routine insider transaction related to compensation and tax obligations, which does not inherently reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 11/16/2021 | Date restricted stock units were granted. |
| 11/17/2025 | Date of the reported transaction (disposition of shares). |
| 11/19/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was filed. |
Keywords
Sarepta Therapeutics, SRPT, Form 4, Insider Transaction, Stock Disposition, Restricted Stock Units, Tax Withholding, Louise Rodino-Klapac
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.